Sector valuations Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.98 USD | -4.60% |
|
-5.46% | +40.18% |
| 06-29 | Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) added to Russell 2500 Growth Benchmark | CI |
| 06-29 | Monte Rosa Therapeutics, Inc.(NasdaqGS:GLUE) dropped from Russell Microcap Value Benchmark Index | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -13.92x | - | -0.05x | - | - | - | - | 1.86B | |
| 35.38x | 4.49x | 1.57x | 6.18x | 19.12x | 26.54x | 0.93% | 50.61B | |
| -23.4x | 18.4x | -0.68x | 342.07x | -22.1x | -21.39x | -.--% | 39.11B | |
| 25.29x | 4.79x | 5.25x | 2.8x | 12.09x | 18.42x | -.--% | 34.64B | |
| 45.73x | 6.69x | 0.29x | 4.5x | 28.9x | 33.42x | -.--% | 33.79B | |
| 27.05x | 2.21x | 0.59x | 7.93x | 19.91x | 23.37x | 0.42% | 26.89B | |
| 31.75x | 15.82x | 2.9x | 5.12x | 23.32x | 24.46x | -.--% | 15.14B | |
| 23.95x | 2.51x | 0.82x | 2.04x | 8.96x | 14.17x | 1.12% | 13.85B | |
| 23.74x | 1.32x | 0.17x | 1.89x | 11.45x | 13.01x | -.--% | 12.72B | |
| -33.62x | 10.2x | 1.38x | 128.84x | -36.68x | -63.82x | -.--% | 11.8B | |
| 38.05x | 3.41x | -0.12x | 3.39x | 13.18x | 16.03x | -.--% | 11.07B | |
| 61.2x | 5.12x | 0.4x | 9.14x | 25.96x | 28.38x | 0.45% | 11.12B | |
| -29.15x | 25.77x | -0.7x | 6.96x | 170.7x | -539.26x | -.--% | 10.04B | |
| -30.97x | 8.96x | -13.6x | 994.1x | -26.35x | -25.82x | -.--% | 10.03B | |
| -33.88x | 8.72x | 7.48x | 100.38x | -22.52x | -21.72x | -.--% | 9.08B | |
| -16.16x | 233.3x | -0.31x | 10.54x | -15.6x | -14.78x | -.--% | 9.38B | |
| -21.4x | 8.09x | -1.69x | 2749.43x | -18.09x | -17.17x | -.--% | 8.77B | |
| -135.38x | 4.7x | 1.07x | 5.32x | 28.22x | 161.68x | -.--% | 8.65B | |
| 19.33x | 2.26x | 1.8x | 4.28x | 11.32x | 14.69x | -.--% | 8.57B | |
| Average | -0.34x | 20.37x | 0.34x | 243.61x | 12.88x | -18.32x | 0.16% | 17.22B | |
| Weighted average by Cap. | 10.89x | 14.30x | 0.82x | 157.37x | 12.12x | -3.88x | 0.24% |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector valuations
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
